Adv Skin Wound Care 2020 Feb;33(2):1-6
Mehak Singh, MD, is in private practice in Bhopal, Madhyapradesh, India. Manoj Pawar, MD, is Assistant Professor, Department of Dermatology, Dr Vasantrao Pawar Medical College, Nashik, India. Acknowledgments: This study investigated the use of topical insulin, which is not FDA approved for topical use. The authors have disclosed no financial relationships related to this article. Submitted December 17, 2018; accepted in revised form July 9, 2019.
Background: Chronic trophic ulcers (CTUs), especially those located over the plantar region, are a leading cause of deformity and disability in patients with leprosy. Despite the various treatment modalities available, CTUs can be chronic and refractory to treatment. The successful use of topical insulin in various types of wounds led researchers to evaluate its safety and efficacy in the treatment of plantar CTUs. Read More